Responsable de toda la estrategia y P&L pública a nivel nacionalEstablecer la estrategia de crecimiento del negocio público junto al CEOLiderar proyectos clave en la parte pública donde convergen la parte social y sanitaria

Healthcare and Pharma MBA Professor at EAE Business School - https://www.eaebarcelona.com/es/mba-en-healthcare-pharma

Responsible of leading and design the strategic plan of the DKV group. Responsible of defining and implement a new relationship model with healthcare professionals and organizations (defining and evolving company organization to improve collaboration and partnerships with healthcare key stakeholders).

Lead the Northeast (Catalonia, Aragon and Balearic Islands) team ( 7 primary care advisors under mysupervision) in improving clinical pathways in primary care centers through the co-creation andimplementation, together with health professionals and primary care managers with a special focus on rheumatological and dermatological pathologies.

Responsible of creating together with Innovative Solutions Head an Innovation Unit in Novartis, finally integrated in Value & Access Unit. The main goal is to improve and accelerate Patient Journey in Health Areas (Hospitals and Primary Care organizations) as a beyond the pill service. My specific responsibilities are:• Lead the creation of the Strategic and Operational Plan (coordinator of Center of Excellence with five people) from patient journey understanding to hospital solutions creation.• Co – creating the team structure (from 4 team members at the beginning to 70 on March 2022),required skills for new positions (FTEs definition, operational and economic ratios, training plan) andinternal governance (office and field coordination with sales, access and medical teams).• Responsible of Digitalization and eHealth strategy and ICT stakeholders’ relation to ensure innovative solutions sustainability and impact maximization throw key Hospital ICT leaders’ collaboration.• Responsible of Value – Based strategy (from product strategy to value and services strategy) definition and execution.• Leading Cardiology (2019), Neurosciences (2020-2021) and Ophthalmology (2020 – 2021 - 2022)specific patient journey strategy and solutions development.Achievements: Spanish Innovative Strategy in Ophthalmology awarded at European Level (more than 40collaboration agreements signed with hospitals and strong results in waiting list reduction (40%average time reduction) and treatment processes and follow up visits optimization). I directlymanaged Andalucian Health Service negotiation. New partnership models implemented in hospitals (6 projects included in tenders and one in asubscription model). Projects under my responsibility included in Novartis Investors Annual Report

Responsible in part of Catalonia for Business, Market Access, Account Management, CommercialOperations and tenders.• Leading the most important organizations for Roche Spain: Institut Català de la Salut (ICS) and Institut Català d’Oncologia and their 11 hospitals.• Managing more than 15 Products and 20 indications and coordinating at the same time four new drugs and seven new indications launches (Atezolizumab, Emicizumab, Ocrelizumab, Pertuzumab, Alectinib and others).• Responsible for negotiating the new position of innovative drugs in a new competitive scenario with the appearance of biosimilars (Rituximab & Trastuzumab).• Responsible of new innovative projects coordinating Roche Farma and Diagnostic in a new NextGeneration Sequencing value added approach.Achievements: Value Added Services added on competitive bidding process for the first time in Spain. Awarded as best field top employee in 2019 for the double – digit sales results obtained and theinnovative collaboration agreements signed with several hospitals in Catalonia. “Jo Innovo” Vall Hebron awards & “C17 Hospital Clinic de Barcelona” awards co-creator.

Rotación temporal en Government Affairs, desarrollando el plan nacional de acceso para Tecentriq - Atezolizumab, la inmunoterapia de Roche para cáncer de pulmón y urotelial.

Business Consultant Manager en Cataluña, Comunidad Valencia, I. Baleares, Murcia, Aragón, Galicia y Portugal. Responsable de la venta, gestión y ejecución de los proyectos de consultoría de la Unidad de Medical de Allergan Iberia.Desarrollo de proyectos de consultoría para grandes corporaciones y clínicas de tamaña medio, focalizados en la optimización de procesos, desarrollo y ejecución de planes de marketing online y tradicional, formación a profesionales médicos y staff, análisis financieros y de rentabilidad de negocio y desarrollo de propuestas de valor para grandes cuentas.También colaboro en el desarrollo de eventos educacionales para profesionales sanitarios y he desarrollado ponencias sobre el sector de la estética en Portugal y España.

Within the Healthcare & Life Sciences team, main focus: driving improvements to chronic care management programs with public and private healthcare providers and the pharmaceutical industry.Specialized in eHealth and Telemedicine projects.

Soporte en la definición de planes funcionales en el ámbito hospitalario.Desarrollo de estudios y análisis de negocio del ámbito de la neurorehabilitación en España.Soporte en oficinas técnicas

Auxiliar administrativo en el departamento de anatomía patológica.Gestión de la entrada y salida de biopsias y otras pruebas del Departamento.

Auxiliar administrativo servicio de urgencias.Gestión de visitas, ingresos y altas de los pacientes.